Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
179 studies found for:    Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed
Has Results
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada;   Other: Placebo
2 Completed Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
3 Completed
Has Results
Effects of Contingency Management for Methamphetamine Abstinence on Post-Exposure Prophylaxis for HIV in Men Who Have Sex With Men (MSM)
Conditions: Amphetamine-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Truvada;   Behavioral: CM
4 Completed
Has Results
TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: Current HAART regimen
5 Completed Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: Atazanavir;   Drug: Ritonavir
6 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
7 Not yet recruiting Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
Condition: HIV Infection
Intervention: Drug: Truvada
8 Active, not recruiting Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
Condition: HIV
Intervention: Drug: Tenofovir/emtricitabine and raltegravir
9 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
10 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
11 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
12 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
13 Completed
Has Results
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz);   Drug: Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV);   Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC)
14 Completed Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
15 Recruiting On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Condition: HIV Infection
Interventions: Drug: Truvada;   Drug: Placebo
16 Unknown  Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
Conditions: Hepatitis B;   HIV Infections
Interventions: Drug: TRUVADA (EMTRICITABINE + TENOFOVIR DF);   Biological: PEGASYS 180μg (Interféron pégylé alpha -2a)
17 Completed GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
Condition: HIV Infections
Interventions: Drug: Truvada (TDF+FTC) alone;   Drug: FTC alone;   Procedure: No HAART
18 Unknown  Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir/emitricitabine);   Drug: Kaletra (lopinavir/ritonavir)
19 Completed Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
Condition: HIV Infections
Interventions: Drug: Zidovudine and Lamivudine (Combivir);   Drug: Emtricitabine and Tenofovir (Truvada)
20 Completed Combination of Efavirenz and Truvada - COMET Study
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years